By Heather Landi
Consumer genetic testing company 23andMe plans to buy Lemonaid Health, a virtual care and pharmacy provider, to integrate its personalized genetics service more deeply into primary care.
read more
By Kyle LaHucik
Repeat biotech founder and MIT professor David Sabatini is biting back against sexual harassment claims that led to his ouster at the Whitehead Institute in August. In a lawsuit filed this week, Sabatini claims the allegations were false and is requesting damages.
read more
By Kevin Dunleavy
The FDA has approved Genentech’s port delivery system for Roche’s Lucentis in patients with wet age-related macular degeneration. Now the trick could be to get patients to accept an implant the size of a grain of rice placed under the upper eyelid that delivers doses of Lucentis and is refilled every six months.
read more
By Andrea Park
With its third multimillion-dollar influx of funding in barely a year, another medtech developer’s plans to create digital therapeutics to treat a wide range of illnesses are clicking into place.
read more
By Paige Minemyer
UnitedHealthcare will adjust claims for COVID-19 vaccines in response to providers who said they were paid sub-Medicare rates to administer the shots.
read more
By Annalee Armstrong
Agenus’ cervical cancer drug balstilimab seemed on its way to FDA approval, but the biotech is now pulling the application after the agency granted full approval to Merck’s Keytruda in the same indication. Agenus Chairman and CEO Garo Armen, Ph.D., has urged the FDA’s Richard Pazdur, M.D., to intervene and allow the company’s therapy to be reviewed under the accelerated pathway, according to a document seen by Fierce Biotech.
read more
By Andrea Park
The phase 2 clinical trial of Ocular Therapeutix’s drug-eluting insert didn’t end in tears, but in this case, that translated to the opposite of success for the proposed treatment for dry eye disease.
read more
By Eric Sagonowsky
When Novartis reported first-half Zolgensma sales a few months ago, the company said its spinal muscular atrophy gene therapy was growing thanks to "expanding access" in Europe. This week at the Fierce Biotech Cell & Gene Therapy event, an exec outlined what's driving the uptake.
read more
By Robert King
HCA Healthcare posted a $2.26 billion profit in the third quarter even as the system weathered an "intense surge" of COVID-19 and higher labor costs.
read more
By Eric Sagonowsky
Eli Lilly has generated billions of dollars from its diabetes drugs over the years, but now the company could be on the line for serious damages by failing to pay royalties on those medicines.
read more
By Andrea Park
Gastroenterologist Austin Chiang, M.D., uses TikTok to bust myths about colonoscopies and normal bowel function. Since joining the social media platform just over two years ago, he has amassed nearly 500,000 followers and a whopping 17.4 million likes on his videos.
read more
By Kyle LaHucik
Athira CEO Leen Kawas altered images in research she conducted while a graduate student at Washington State University in the early 2010s. The altered research did not impact Athira Pharma's lead candidate, but the CEO is officially out after an independent investigation, and COO Mark Litton will replace her.
read more
